WASHINGTON/GENEVA – The United States, European Union, India and South Africa have reached a tentative agreement on key elements of a long-sought limited intellectual property (IP) waiver for COVID-19 vaccines, sources familiar with the deal said Tuesday.
The tentative agreement among the four members of the World Trade Organization (WTO) still needs formal approvals from the parties before it can be considered official, the sources said.
Unable to view this article?
This could be due to a conflict with your ad-blocking or security software.
Please add japantimes.co.jp and piano.io to your list of allowed sites.
We humbly apologize for the inconvenience.